We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $717B
1-Year Est. Return 35.42%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+15.07%
1 Year Est. Return
+35.42%
3 Year Est. Return
+133.7%
5 Year Est. Return
+183.13%
10 Year Est. Return
+734.77%
AUM
$315B
AUM Growth
+$28.4B
Cap. Flow
-$8.21B
Cap. Flow %
-2.6%
Top 10 Hldgs %
26.98%
Holding
442
New
25
Increased
151
Reduced
166
Closed
27

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.42B
2
VALE icon
Vale
VALE
+$1.05B
3
FCX icon
Freeport-McMoran
FCX
+$988M
4
MU icon
Micron Technology
MU
+$690M
5
XOM icon
ExxonMobil
XOM
+$534M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.21B
2
TRP icon
TC Energy
TRP
+$1.37B
3
MSFT icon
Microsoft
MSFT
+$1.32B
4
VZ icon
Verizon
VZ
+$1.31B
5
AMZN icon
Amazon
AMZN
+$940M

Sector Composition

Rank Sector Weight
1 Healthcare 20.11%
2 Technology 16.54%
3 Communication Services 12.92%
4 Consumer Discretionary 12.55%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VALE icon
26
Vale
VALE
$61.4B
$3.17B 1%
242,540,374
+81,531,032
+51% +$1.05B
KO icon
27
Coca-Cola
KO
$373B
$3.12B 0.99%
66,661,733
-4,101,569
-6% -$192M
ACN icon
28
Accenture
ACN
$110B
$3.12B 0.99%
17,719,131
+1,217,199
+7% +$191M
HD icon
29
Home Depot
HD
$342B
$3.11B 0.99%
16,200,719
+887,620
+6% +$163M
SYK icon
30
Stryker
SYK
$133B
$3.04B 0.96%
15,371,625
+1,535,630
+11% +$276M
WP
31
DELISTED
Worldpay, Inc.
WP
$2.74B 0.87%
24,163,622
-290,796
-1% -$26.4M
MAR icon
32
Marriott International
MAR
$92.5B
$2.71B 0.86%
21,667,104
+1,034,493
+5% +$122M
LIN icon
33
Linde
LIN
$221B
$2.65B 0.84%
15,087,075
+2,315,736
+18% +$385M
MCD icon
34
McDonald's
MCD
$195B
$2.54B 0.81%
13,384,337
-2,323
-0% -$422K
JPM icon
35
JPMorgan Chase
JPM
$971B
$2.52B 0.8%
24,890,148
-276,336
-1% -$28.5M
CXO
36
DELISTED
CONCHO RESOURCES INC.
CXO
$2.49B 0.79%
22,442,393
+1,376,098
+7% +$156M
COST icon
37
Costco
COST
$421B
$2.47B 0.78%
10,203,402
+269,512
+3% +$58.9M
CNQ icon
38
Canadian Natural Resources
CNQ
$98.1B
$2.36B 0.75%
175,775,862
+5,426,055
+3% +$72.1M
BKNG icon
39
Booking.com
BKNG
$159B
$2.15B 0.68%
30,812,725
+2,944,600
+11% +$210M
LMT icon
40
Lockheed Martin
LMT
$140B
$2.13B 0.67%
7,088,572
+932
+0% +$273K
TXN icon
41
Texas Instruments
TXN
$253B
$2.02B 0.64%
19,018,738
-943,871
-5% -$97.8M
TEVA icon
42
Teva Pharmaceuticals
TEVA
$42.8B
$2.01B 0.64%
128,191,392
+6,237,109
+5% +$110M
CME icon
43
CME Group
CME
$94.3B
$1.98B 0.63%
12,055,619
+640,467
+6% +$113M
NOW icon
44
ServiceNow
NOW
$129B
$1.9B 0.6%
38,608,250
+8,382,165
+28% +$369M
AEP icon
45
American Electric Power
AEP
$67.9B
$1.89B 0.6%
22,529,098
+569,960
+3% +$45.3M
D icon
46
Dominion Energy
D
$59.8B
$1.88B 0.6%
24,506,784
+421,428
+2% +$30.8M
ILMN icon
47
Illumina
ILMN
$29.1B
$1.86B 0.59%
6,163,720
-89,903
-1% -$26.2M
BRK.B icon
48
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.85B 0.59%
9,218,529
-863,651
-9% -$174M
FCX icon
49
Freeport-McMoran
FCX
$96.9B
$1.83B 0.58%
141,985,681
+81,665,941
+135% +$988M
AIG icon
50
American International
AIG
$39.8B
$1.83B 0.58%
42,459,285
-2,046,967
-5% -$87.5M

Similar funds

Capital Research Global Investors's Q1 2019 Portfolio in Review

As of Q1 2019, Capital Research Global Investors held 442 positions worth $315B, up 9.9% from $287B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Capital Research Global Investors's Q1 2019 filing shows 25 new, 151 increased, 166 reduced and 27 closed positions. Its largest new stake was Micron Technology: 17,867,672 shares worth $738M. The largest sale was AbbVie, an estimated $2.21B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.

  • Capital Research Global Investors's largest Q1 2019 buy was Micron Technology: 17,867,672 shares worth $738M.
  • Capital Research Global Investors added most to Alibaba in Q1 2019, an estimated $1.42B increase.
  • Capital Research Global Investors's biggest Q1 2019 reduction was AbbVie, cutting an estimated $2.21B.
  • Capital Research Global Investors fully exited TC Energy in Q1 2019, selling an estimated $1.37B.
  • Capital Research Global Investors's ten largest holdings make up 27% of its $315B portfolio in Q1 2019.
  • Capital Research Global Investors opened 25 new positions and closed 27 in Q1 2019.
  • Capital Research Global Investors's portfolio value rose 9.9% quarter-over-quarter to $315B.

Based on Capital Research Global Investors's 13F filing for Q1 2019, filed 15 May 2019.